Cover Image
市場調查報告書

脫髮症:全球臨床實驗趨勢

Alopecia Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 235289
出版日期 內容資訊 英文 163 Pages
訂單完成後即時交付
價格
Back to Top
脫髮症:全球臨床實驗趨勢 Alopecia Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月31日 內容資訊: 英文 163 Pages
簡介

本報告提供脫髮症的治療藥相關臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及各期狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:脫髮症臨床實驗數量佔皮膚病臨床實驗數量比率

各期臨床實驗數量:G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:脫髮症臨床實驗數量佔皮膚病臨床實驗數量比率

各期臨床實驗數量:E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參與企業 - 脫髮症治療藥

有潛力的藥劑

最新臨床實驗新聞:脫髮症

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Alopecia Global Clinical Trials Review, H1, 2017" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Alopecia Therapeutics Clinical Trials 29
  • Prominent Drugs 31
  • Latest Clinical Trials News on Alopecia 32
  • Mar 04, 2017: Concert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual Meeting 32
  • Clinical Trial Profile Snapshots 33

Appendix 161

  • Abbreviations 161
  • Definitions 161
  • Research Methodology 162
  • Secondary Research 162
  • About GlobalData 163
  • Contact Us 163
  • Source 163

List of Tables

  • Alopecia Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Alopecia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Alopecia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Alopecia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Alopecia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Alopecia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Alopecia to Dermatology Clinical Trials, G7 Countries (%), 2017* 15
  • Alopecia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Alopecia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Alopecia to Dermatology Clinical Trials, E7 Countries (%), 2017* 18
  • Alopecia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Alopecia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Alopecia Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Alopecia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Alopecia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Alopecia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Alopecia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Alopecia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Alopecia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Alopecia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Alopecia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures

  • Alopecia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countri
Back to Top